We are live on ! Find out more
NEXI

NexImmune, Inc. Common Stock
NEXI

Delisted

NEXI was delisted on the 11th of July, 2024.

Back to rankings

38 hedge funds and large institutions have $4.34M invested in NexImmune, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less funds holding

Funds holding: 44 → 38 (-6)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

67% less capital invested

Capital invested by funds: $13.4M → $4.34M (-$9.02M)

Holders
38
Holders Change
-6
Holders Change %
-13.64%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
7
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KHCM
Kettle Hill Capital Management
New York
+$115K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$31.7K
3
Man Group
Man Group
United Kingdom
+$23.8K
4
Renaissance Technologies
Renaissance Technologies
New York
+$14.9K
5
SEI Investments
SEI Investments
Pennsylvania
+$14.2K

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$419K
2
E
Ergoteles
New York
-$139K
3
Citadel Advisors
Citadel Advisors
Florida
-$68K
4
Goldman Sachs
Goldman Sachs
New York
-$47K
5
B
Bailard
California
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
1
Artal Group
Luxembourg
$666K – – –
ACH
2
ArrowMark Colorado Holdings
Colorado
$537K -$419K -14,281 -27%
SPC
3
Slate Path Capital
New York
$513K – – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$444K – – –
AO
5
Allen Operations
New York
$353K – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
$291K – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$263K +$31.7K +1,082 +6%
BM
8
Bridger Management
New York
$222K – – –
ECG
9
EPIQ Capital Group
California
$217K – – –
KHCM
10
Kettle Hill Capital Management
New York
$206K +$115K +3,930 +36%
Millennium Management
11
Millennium Management
New York
$90K -$23.3K -795 -11%
MCM
12
M28 Capital Management
Connecticut
$74K – – –
BBHC
13
Brown Brothers Harriman & Co
New York
$68K – – –
PNC Financial Services Group
14
PNC Financial Services Group
Pennsylvania
$62K – – –
6CM
15
683 Capital Management
New York
$56K – – –
First Manhattan
16
First Manhattan
New York
$36K -$29.3K -1,000 -27%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$34K – – –
CG
18
Caprock Group
Idaho
$31K – – –
BCM
19
Bridgeway Capital Management
Texas
$28K – – –
SEI Investments
20
SEI Investments
Pennsylvania
$21K +$14.2K +485 +46%
RJA
21
Raymond James & Associates
Florida
$17K – – –
BlackRock
22
BlackRock
New York
$16K -$17.1K -584 -33%
Rockefeller Capital Management
23
Rockefeller Capital Management
New York
$15K – – –
State Street
24
State Street
Massachusetts
$13K – – –
Man Group
25
Man Group
United Kingdom
$11K +$23.8K +813 New
1
2

NEXI Hedge Fund Activity: Q3 2022 in Review

38 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q3 2022, worth a combined $4.34M — down 67% from $13.4M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of NEXI and 6 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Kettle Hill Capital Management, adding an estimated $115K. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $419K.

  • 38 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q3 2022, down from 44 in Q2 2022.
  • Funds reported $4.34M of NexImmune, Inc. Common Stock stock for Q3 2022, down 67% quarter-over-quarter.
  • 6 funds opened new NexImmune, Inc. Common Stock positions in Q3 2022 and 12 closed out, a net change of -6 holders.
  • The largest NexImmune, Inc. Common Stock buyer in Q3 2022 was Kettle Hill Capital Management, an estimated $115K added.
  • The largest NexImmune, Inc. Common Stock seller in Q3 2022 was ArrowMark Colorado Holdings, an estimated $419K sold.

Based on aggregated 13F filings for Q3 2022.